Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung Disease

Clinical trial NCT04154826 · TERMINATED

Trial details

NCT number: NCT04154826
Sponsor: Revimmune
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Mycobacterium Infections, Nontuberculous

Start date: 2020-11-30
Primary completion: 2023-12-31
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.